Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Ending Cash Position: NT$330.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1762 Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
67 GF Score
Price NT$33.70
GF Value NT$37.99
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Chunghwa Chemical Synthesis & Biotech Co Ending Cash Position?

Chunghwa Chemical Synthesis & Biotech Co TPE:1762 -3.02% 67 Ending Cash Position is NT$330.0 Mil as of Jun. 2026. GuruFocus rates TPE:1762 with a GF Score™ of 67/100 and a GF Value™ of NT$37.99 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Chunghwa Chemical Synthesis & Biotech Co's Ending Cash Position for the quarter that ended in Jun. 2026 was NT$330.0 Mil.

Chunghwa Chemical Synthesis & Biotech Co's quarterly Ending Cash Position increased from Dec. 2025 (NT$216.4 Mil) to Mar. 2026 (NT$286.5 Mil) and increased from Mar. 2026 (NT$286.5 Mil) to Jun. 2026 (NT$330.0 Mil).

Chunghwa Chemical Synthesis & Biotech Co's annual Ending Cash Position declined from Dec. 2023 (NT$269.6 Mil) to Dec. 2024 (NT$222.3 Mil) and declined from Dec. 2024 (NT$222.3 Mil) to Dec. 2025 (NT$216.4 Mil).

Chunghwa Chemical Synthesis & Biotech Co Ending Cash Position Related Terms

Chunghwa Chemical Synthesis & Biotech Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chunghwa Chemical Synthesis & Biotech Co Ending Cash Position Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 195.25 300.61 269.57 222.28 216.44

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 214.10 253.19 216.44 286.49 329.96
TPE:1762
67GF Score
Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chunghwa Chemical Synthesis & Biotech Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Chunghwa Chemical Synthesis & Biotech Co's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=222.275+-5.838
=216.4

Chunghwa Chemical Synthesis & Biotech Co's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=286.487+43.469
=330.0

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of NT$330.0 Mil mean?
Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) has a Ending Cash Position of NT$330.0 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors.
Is Chunghwa Chemical Synthesis & Biotech Co's Ending Cash Position too high?
Chunghwa Chemical Synthesis & Biotech Co's current Ending Cash Position is NT$330.0 Mil. Overall, Chunghwa Chemical Synthesis & Biotech Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chunghwa Chemical Synthesis & Biotech Co's Ending Cash Position compare to VRTX and REGN?
Chunghwa Chemical Synthesis & Biotech Co's Ending Cash Position of NT$330.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors. Chunghwa Chemical Synthesis & Biotech Co's current Ending Cash Position is NT$330.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chunghwa Chemical Synthesis & Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$37.99, compared to a current price of NT$33.70 — trading 11.3% below its estimated fair value. The current Ending Cash Position is NT$330.0 Mil. Chunghwa Chemical Synthesis & Biotech Co's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Chunghwa Chemical Synthesis & Biotech Co (TPE:1762), the current Ending Cash Position is NT$330.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Overvalued in 2026?

Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co stock appears to be undervalued. The current stock price of NT$33.70 is trading 11.3% below its estimated GF Value™ of NT$37.99. GuruFocus considers Chunghwa Chemical Synthesis & Biotech Co to be Modestly Undervalued.

Key valuation signals for TPE:1762:

  • Ending Cash Position: NT$330.0 Mil
  • GF Value™: NT$37.99 vs. price of NT$33.70 (11.3% below fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the TPE:1762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chunghwa Chemical Synthesis & Biotech Co Business Description

Address No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.
67GF Score

Get the complete analysis for TPE:1762

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.70
Price
NT$37.99
GF Value